BrainCo files for Hong Kong IPO — would be first BCI company to go public globally
Summary
Bloomberg reported that BrainCo has quietly filed for a Hong Kong IPO following its ¥2 billion ($286M) funding round — a move that would make it the first brain-computer interface company to achieve a public listing globally, preceding both Neuralink and Synchron in public market access. BrainCo's product portfolio includes commercially deployed EEG headbands for neurofeedback and cognitive training across China's education and healthcare markets, and the FutureHand myoelectric prosthetic. The Hong Kong Stock Exchange's technology-friendly listing environment and proximity to BrainCo's investor base make it the natural IPO venue.
Why it matters
BrainCo going public before Neuralink or Synchron would establish the first public market valuation benchmark for a BCI company — one based on commercial revenue from deployed products rather than clinical-stage development. That benchmark will influence how investors value all subsequent BCI company financings and IPOs, including Neuralink's eventual IPO. A BrainCo public listing also provides Chinese retail and institutional investors direct exposure to BCI, broadening the investor base for the entire sector.
Want the full NeurotechMag Pro intelligence database?
Access 800+ papers, trials, patents, funding rounds and news items — updated daily.
Start free trial